Morgan Stanley Bio Restorative Therapies, Inc. Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Morgan Stanley holds 15,000 shares of BRTX stock, worth $24,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 10,000
50.0%
Holding current value
$24,000
Previous $13,000
130.77%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BRTX
# of Institutions
14Shares Held
249KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA52.3KShares$83,7390.0% of portfolio
-
Stone X Group Inc.50.1KShares$80,1600.01% of portfolio
-
Wealth Alliance Mellville, NY40KShares$64,0000.01% of portfolio
-
Ubs Group Ag27.8KShares$44,5000.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.5KShares$32,7550.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $5.84M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...